Charles Cotropia

Charles Cotropia

Corporate Officer/Principal at
State Bar of Texas
Commercial Services
Consumer Services
Health Technology

Profile

Charles S.
Cotropia
was the founder of Bioclonetics Immunotherapeutics, Inc. (founded in 2009) where he served as the Chief Executive Officer & Director from 2009 to 2020.
He is currently the President & Director at Biogenysis, Inc. and a Member of the State Bar of Texas.
Previously, he was the President, Chief Executive Officer & Director at Enzolytics, Inc. from 2020 to 2024.
He also held the position of Director at the Dallas Bar Association.
Prior to that, he worked as Senior Counsel at Sidley Austin LLP from 1973 to 2015.
Mr. Cotropia obtained his undergraduate degree from The University of Texas at Austin and his graduate degree from Cornell University.

Charles Cotropia active positions

CompaniesPositionStart
Corporate Officer/Principal -

Former positions of Charles Cotropia

CompaniesPositionEnd
ENZOLYTICS, INC. Chief Executive Officer 19/03/2024
President 23/02/2024
Founder 01/12/2020
General Counsel 01/01/2015
Director/Board Member -
See the detail of Charles Cotropia's experience

Training of Charles Cotropia

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

100 +

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Commercial Services

Commercial Services

  1. Stock Market
  2. Insiders
  3. Charles Cotropia
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!